2nd ESG in Life Sciences Summit Europe Mercure Amsterdam City Hotel, Amsterdam

With the CSRD integrated into national laws in July 2024, the first reporting requirements due in Q1 2025, and thousands more companies coming under its scope by Q1 2026, the urgency for Life Sciences companies to decipher and apply these new European reporting standards has never been greater. At the same time, mounting pressure from investors, consumers, and employees to accelerate environmental and social initiatives is leaving many searching for the most effective strategies to navigate the evolving ESG landscape.

Yet, with significant uncertainty around how these new regulations should be applied to Life Sciences and a rapidly shifting ESG agenda, many companies are struggling to identify the right initiatives that will deliver the biggest sustainability impact while ensuring compliance.

The 2nd ESG in Life Sciences Summit Europe is designed to bring together senior leaders in ESG, Sustainability, Compliance, Supply Chain, and Finance, providing actionable insights into the CSRD, CSDDD, and European Reporting Requirements, while tackling single-use plastic, equitable access to medicine, Scope 3 transparency, and more-ultimately empowering companies to build a market-leading ESG framework for long-term success.